Ascend Wellness Holdings (AAWH) Common Equity (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Common Equity of -$76.6 million in Q1 2026, down 64.3% quarter-over-quarter from -$46.6 million in Q4 2025, and down 245.33% on a YoY basis from $52.7 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Common Equity (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Common Equity history runs 7 years deep, the most recent figure standing at -$76.6 million for Q1 2026.
- In Q1 2026, Common Equity fell 245.33% year-over-year to -$76.6 million; the TTM figure through Mar 2026 stood at -$76.6 million (down 245.33% YoY), while the FY2025 annual figure was -$46.6 million, down 164.93% from the prior year.
- Common Equity was -$76.6 million for Q1 2026 at Ascend Wellness Holdings, down from -$46.6 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $186.6 million in Q2 2022 to a low of -$76.6 million in Q1 2026.
- Historically, Common Equity has averaged $98.5 million across 5 years, with a median of $135.8 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Common Equity surged 1188.41% in 2022, then tumbled 245.33% in 2026.
- A 5-year view of Common Equity shows it stood at $163.4 million in 2022, then decreased by 12.57% to $142.9 million in 2023, then slumped by 49.74% to $71.8 million in 2024, then plunged by 164.93% to -$46.6 million in 2025, then tumbled by 64.3% to -$76.6 million in 2026.
- The last three Common Equity figures came in at -$76.6 million (Q1 2026), -$46.6 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -76.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.59 Mn |
| Dec 31, 2025 | -46.62 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 28.15 Mn |
| Mar 31, 2025 | 52.70 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Sep 30, 2024 | 88.91 Mn |
| Jun 30, 2024 | 117.54 Mn |
| Mar 31, 2024 | 135.83 Mn |
| Dec 31, 2023 | 142.87 Mn |
| Sep 30, 2023 | 159.47 Mn |
| Jun 30, 2023 | 165.96 Mn |
| Mar 31, 2023 | 148.96 Mn |
| Dec 31, 2022 | 163.42 Mn |
| Sep 30, 2022 | 174.07 Mn |
| Jun 30, 2022 | 186.62 Mn |
| Mar 31, 2022 | 158.03 Mn |
| Dec 31, 2021 | 176.48 Mn |
| Sep 30, 2021 | 184.04 Mn |
| Jun 30, 2021 | 189.32 Mn |